Korro Bio (KRRO) EBITDA Margin (2019 - 2025)
Korro Bio's (KRRO) quarterly EBITDA Margin came in at 3900.62% in Q4 2025, down 288609.0% YoY from N/an in Q4 2024, and down 121.02% on a QoQ basis from 1764.86% in Q3 2025.
Korro Bio (KRRO) EBITDA Margin (2019 - 2025) Analysis & Trends
Korro Bio (KRRO) has 5 years of EBITDA Margin data on file, last reported at 3900.62% in Q4 2025.
- Quarterly EBITDA Margin fell 288609.0% year-over-year to 3900.62% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 3052.34% (down 107190.0% YoY) and the FY2025 annual result came in at 1906.37%, up 214075.0% from the prior year.
- EBITDA Margin retreated to 3900.62% in Q4 2025, from 1764.86% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 185.65% in Q2 2021 to a low of 3900.62% in Q4 2025.
- A 3-year average of 1449.18% and a median of 1014.53% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2021 — EBITDA Margin plunged 11291 bps — and 2025, when it sank 288609 bps.
- Tracing KRRO's EBITDA Margin over 3 years: stood at 185.65% in 2021, then slumped by 446 bps to 1014.53% in 2024, then slumped by 284 bps to 3900.62% in 2025.
- The last three EBITDA Margin figures came in at 3900.62% (Q4 2025), 1764.86% (Q3 2025), and 1863.15% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Korro Bio | 228.60 Mn | 113.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,900.62% |
| Sep 30, 2025 | -1,764.86% |
| Jun 30, 2025 | -1,863.15% |
| Mar 31, 2025 | -981.18% |
| Dec 31, 2024 | -1,014.53% |
| Jun 30, 2021 | -185.65% |
| Mar 31, 2021 | -434.29% |
| Dec 31, 2020 | -103.29% |
| Sep 30, 2020 | -48.17% |
| Jun 30, 2020 | -72.74% |
| Mar 31, 2020 | -77.85% |
| Dec 31, 2019 | -137.78% |
| Sep 30, 2019 | -5.17% |